本页面由Tiger Trade Technology Pte. Ltd.提供服务

Phathom Pharmaceuticals

11.32
+0.78987.50%
成交量:44.66万
成交额:494.40万
市值:8.92亿
市盈率:-3.73
高:11.32
开:10.76
低:10.75
收:10.53
52周最高:18.31
52周最低:2.21
股本:7,879.87万
流通股本:5,756.69万
量比:0.47
换手率:0.78%
股息:- -
股息率:- -
每股收益(TTM):-3.0342
每股收益(LYR):-3.0342
净资产收益率:-3489.00%
总资产收益率:-31.37%
市净率:-2.04
市盈率(LYR):-3.73

数据加载中...

2025/03/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/06

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/06

重要事件披露

Form 8-K - Current report
2024/12/11

重要事件披露

Form 8-K - Current report
2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/08/22

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/19

重要事件披露

Form 8-K - Current report
2024/08/19

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/07/18

重要事件披露

Form 8-K - Current report
2024/06/15

SEC问询函

Form CORRESP - Correspondence
2024/06/14

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/06/14

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/06/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/10

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]